Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Carbetocin (Primary) ; Misoprostol (Primary) ; Oxytocin (Primary)
- Indications Postpartum haemorrhage
- Focus Therapeutic Use
- 30 May 2013 Planned end date changed from 1 Feb 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 09 Oct 2012 Additional lead trial centre added and primary endpoint amended as reported by ClinicalTrials.gov.
- 01 Sep 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.